Advertisement
Advertisement
CRL
Charles River Laboratories International, Inc.
167.13
USDSponsored
+1.24
+0.75%
Mar 26, 10:57 UTC -4
Open
CRL Earnings Reports
Positive Surprise Ratio
CRL beat 40 of 40 last estimates.
100%
Next Report
Date of Next Report
May 05, 2026
Estimate for Q1 26 (Revenue/ EPS)
$990.16M
/$1.94
Implied change from Q4 25 (Revenue/ EPS)
-0.41%
/-18.83%
Implied change from Q1 25 (Revenue/ EPS)
+0.61%
/-17.09%
Charles River Laboratories International, Inc. earnings per share and revenue
On Feb 18, 2026, CRL reported earnings of 2.39 USD per share (EPS) for Q4 25, beating the estimate of 2.36 USD, resulting in a 0.98% surprise. Revenue reached 994.23 million, compared to an expected 996.87 million, with a -0.26% difference. The market reacted with a -0.33% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 13 analysts forecast an EPS of 1.94 USD, with revenue projected to reach 990.16 million USD, implying an decrease of -18.83% EPS, and decrease of -0.41% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
HealthEquity, Inc
Report Date
Mar 17, 2026 For Q4 26
Estimate
$0.90
Actual
$0.95
Surprise
+4.51%
The Oncology Institute, Inc. Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.09
Actual
-$0.06
Surprise
+33.99%
The Beauty Health Company Class A Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.06
Surprise
-14.29%
Sera Prognostics, Inc. Class A Common Stock
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.16
Surprise
+17.44%
DocGo Inc. Common Stock
Report Date
Mar 16, 2026 For Q4 25
Estimate
-$0.13
Actual
-$1.37
Surprise
-920.10%
IceCure Medical Ltd. Ordinary Shares
Report Date
Mar 17, 2026 For Q4 25
Estimate
-$0.04
Actual
-$0.07
Surprise
-52.51%
Lifeward Ltd. Ordinary Shares
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$1.10
Actual
-$3.60
Surprise
-226.80%
SeaStar Medical Holding Corporation Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$1.07
Actual
-$0.80
Surprise
+25.28%
Healthy Choice Wellness Corp.
Report Date
Mar 16, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.05
Surprise
+1.96%
Aclarion, Inc. Common Stock
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$3.67
Actual
-$2.54
Surprise
+30.83%
FAQ
What were Charles River Laboratories International, Inc.'s earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Charles River Laboratories International, Inc. reported EPS of $2.39, beating estimates by 0.98%, and revenue of $994.23M, -0.26% below expectations.
How did the market react to Charles River Laboratories International, Inc.'s Q4 2025 earnings?
The stock price moved down -0.33%, changed from $158.53 before the earnings release to $158.00 the day after.
When is Charles River Laboratories International, Inc. expected to report next?
The next earning report is scheduled for May 05, 2026.
What are the forecasts for Charles River Laboratories International, Inc.'s next earnings report?
Based on 13
analysts, Charles River Laboratories International, Inc. is expected to report EPS of $1.94 and revenue of $990.16M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement